Navigation Links
TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
Date:11/8/2011

SCOTTSDALE, Ariz. -- The Virginia G. Piper Cancer Center at Scottsdale Healthcare is expanding its efforts to accelerate advances in cancer care with the addition of Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute in Los Angeles as a collaborator in clinical trials to develop personalized therapies that could lead to more effective cancer treatments.

The collaboration will focus on Phase I clinical trials of new personalized therapies for a variety of rare and common cancers, focusing on three areas of cancer research:

  • Gastrointestinal malignancies including pancreatic, colorectal and gastric cancer
  • Genitourinary malignancies such as prostate, kidney and bladder cancer
  • Rare cancers including adrenal, neuroendocrine and thyroid cancer

Virginia G. Piper Cancer Center Clinical Trials, a partnership between the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, will provide local coordination for the program. The partnership offers patients access to promising new cancer treatments through clinical trials, emphasizing collaboration among leading organizations to speed innovation from laboratory bench to patient bedside.

The collaborative endeavor between TGen, Virginia G. Piper Cancer Center and Cedars-Sinai also will study new approaches to improve patients' quality of life during cancer treatment and create innovative models to deliver supportive care and services to cancer survivors.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare serves the greater Phoenix area with innovative cancer treatment and research facilities that attract patients from across Arizona and the United States.

"In addition to our local patients a significant number travel from the west coast for treatment at the Virginia G. Piper Cancer Center. The opportunity to expand our collective efforts against these cancers will undoubtedly mean progress in medicine's ability to successfully treat the disease," said Dr. Ramesh Ramanathan, M.D., Medical Director, Virginia G. Piper Cancer Center Clinical Trials, and Deputy Director of TGen's Clinical Translational Research Division.

Cedars-Sinai is the largest academic medical center in the western U.S. Its outpatient cancer center treats more than 9,000 patients each year, making it one of the busiest treatment facilities in California. Earlier this year, U.S. News & World Report named the institute's cancer program as one of the top in the country.

"Our two organizations share the same goal: to greatly improve cancer treatment with therapies that attack the disease in new and innovative ways," added Steven Piantadosi, M.D., Ph.D., Phase One Foundation chair and director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. "Translating new research into effective therapies will improve the lives of cancer patients, and, ultimately, lead to a time when cancer is a manageable condition not a feared disease."

The Virginia G. Piper Cancer Center at Scottsdale Healthcare opened in December 2001 as the first comprehensive cancer center in greater Phoenix and ranks as one of the country's leading programs for new cancer drug development and Phase I studies.

"We are very excited about this new collaboration intended to accelerate development of new ways to beat cancer," said Tom Sadvary, president & CEO of Scottsdale Healthcare. "Our two organizations share the same commitment to improving the lives of our patients and expanding the ever-increasing number of cancer survivors."

Individuals seeking information about eligibility to participate in clinical trials at the Virginia G. Piper Cancer Center at Scottsdale Healthcare may contact the cancer care coordinator at 480-323-1339; toll free at 1-877-273-3713; or via email at clinicaltrials@shc.org.


'/>"/>
Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Virginia Commonwealth University findings may help explain high blood pressure in pregnancy
2. Virginia Commonwealth University study: We are what we experience
3. TGen/Virginia G. Piper Cancer Center publish results of new drug for pancreatic cancer patients
4. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
5. Months After Shootings, Many Virginia Tech Students Suffered PTSD
6. TGen, Virginia G. Piper Cancer Center studying new breast cancer drug
7. VCU Massey Cancer Center awarded $2.4 million grant from Virginia Tobacco Commission
8. Virginia Bioinformatics Institute to model immune responses to gut pathogens
9. Virginia Tech professor discovers new TB pathogen
10. VCU first Virginia institution to join national network of academic research centers
11. Dr. Phillip Chang Introduces New Ways to Decrease Scars and Potential Complications For Breast Augmentations in Loudoun and Fairfax Virginia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization ... a partnership with San Ramon Regional Medical Center. Under the collaboration, the first of ... way to accommodate a more certain time frame for donor families for the recovery ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... OAKLAND, Calif. , Feb. 11, 2016  Walgreens ... stores across 39 states and Washington, D.C. ... in a move that was commended by shareholder advocacy organization ... President at As You Sow. "Many people hold on to ... options, which can have tragic consequences." --> ...
(Date:2/11/2016)... 2016  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and other birth tissues, human skin and bone, and ... advanced products and therapies, announced today that it will ... Conference in New York , NY.  ... J. Senken , Chief Financial Officer and Chris ...
Breaking Medicine Technology: